← NewsAll
Toronto General Hospital ranked second-best in the world.
Summary
Newsweek's 2026 World's Best Hospitals list placed Toronto General Hospital second globally, up one spot from last year; Mayo Clinic ranked first and Cleveland Clinic third.
Content
Newsweek's 2026 World's Best Hospitals list has ranked Toronto General Hospital as the second-best hospital in the world, moving it up one spot from last year. The list was produced in partnership with Statista and used expert surveys, patient experience data and quality metrics. Toronto General is part of University Health Network and is known for cardiac care, organ transplants and treating complex patient needs. UHN's leadership noted recent recruitment of researchers and connections to clinical trials as part of its explanation for the rise in ranking.
Ranking details:
- Newsweek and Statista produced the 2026 World's Best Hospitals list and ranked 250 hospitals using surveys and metrics drawn from data on more than 2,500 hospitals across 32 countries.
- Toronto General moved to second place, behind Mayo Clinic in Rochester, Minnesota, while Cleveland Clinic moved to third.
- University Health Network President and CEO Kevin Smith said UHN has recruited 43 people so far toward a goal of 50, and that more than 700 candidates have expressed interest.
- Smith attributed some hiring opportunities to reduced research investment in the United States and mentioned research areas including viruses, vaccines, cancer, heart disease and health equity.
- UHN operates 10 sites, including Toronto Western Hospital, Princess Margaret Cancer Centre and Toronto Rehabilitation Institute.
- Within the city, Mount Sinai Hospital rose to 27th on the list and Sunnybrook Health Sciences Centre moved from 24th to 30th.
Summary:
The ranking underlines Toronto General's continued presence among the world's top hospitals and highlights UHN's emphasis on research and targeted recruitment. UHN says it is working toward hiring 50 researchers and continues to manage the timelines for federal approvals and provincial funding as it expands research and clinical trials.
